Skip to main content
Equibles
HCWC logo

HCWC · Healthy Choice Wellness Corp.

Track HCWC — free

Use HCWC with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$7.18 -0.26 (-3.49%) At close · Sep 2
Rebalance outlook locked
Going-concern doubt — cleared Aug 14, 2026

The latest filing states the doubt was alleviated.

“These conditions, among others, raise substantial doubt about the Company's ability to continue as a going concern within one year after the date these financial statements are issued. Based on the above, management has concluded that its plans, including the operational cost-saving initiatives and the financing arrangements described above, alleviate the substantial doubt raised by the Company's historical operating results and financial condition.”
View the 10-Q filed Aug 14, 2026
Market Cap
$6.70M
Shares
927,367

HCWC metrics

41 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$7.18
Market cap
$6.70M

Price action

19 metrics
Price change (1W)
—
Price change (30D)
-11.5%
Price change (3M)
—
Price change (6M)
—
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
—
Beta
—
RSI (14D)
—
Price vs SMA 50
—
Price vs SMA 200
—
Avg volume (3M)
—
Relative volume
—
Average dollar volume
—

Company

3 metrics
Sector
Consumer Defensive
Industry
Grocery Stores
Shares outstanding
927,367

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.1×
reciprocal yield 1,083.6%
P / book
1.9
reciprocal yield 52.3%
FCF yield
-40.3%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-143.7%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
0.2×
reciprocal yield 645.2%
EV / revenue historical average (5Y)
0.2×
reciprocal yield 645.2%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
38.6%
Operating margin
-8.7%
Trailing 12 months
Net margin
-13.3%
Gross profit (TTM)
$28.06M
Operating profit (TTM)
−$6.29M
Net income (TTM)
−$9.63M
Trailing 12 months
Diluted EPS (TTM)
$-14.70
FCF margin
-3.7%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$31,458,427.00

Growth

11 metrics
Revenue growth YoY
-17.8%
Year over year
Net income growth YoY
—
Revenue (TTM)
$72.60M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+122.9%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-274.8%
Return on assets
-34.7%
Debt / equity
—
Current ratio
0.5
EBITDA (TTM)
−$4.70M
Free cash flow (TTM)
−$2.70M
Quick ratio
0.2
Interest coverage
-8.0
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$900,000
Total assets
$27.74M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$2.36M
Capital expenditures (TTM)
$334,971
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
38
13F filer change QoQ
+3
Institutional ownership
3.2%

Short interest

3 metrics
Short interest
6.4%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
64 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1948864 CUSIP 42227T105 13F (30d) 28 filings 28 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)